Nautilus Biotechnology Inc (NAS:NAUT)
$ 2.36 +0.035 (+1.51%) Market Cap: 299.91 Mil Enterprise Value: 232.91 Mil PE Ratio: 0 PB Ratio: 2.07 GF Score: 28/100

Nautilus Biotechnology Inc Annual Shareholders Meeting Transcript

Jun 17, 2026 / 05:00PM GMT
Release Date Price: $2.18 (+0.46%)
Sujal Patel
Nautilus Biotechnology Inc - President, Chief Executive Officer, Secretary, Director

Good morning, ladies and gentlemen. I'm Sujal Patel, and I'm the President and Chief Executive Officer and a member of the Board of Directors of Nautilus Biotechnology, Incorporated. It's a pleasure to welcome you to the 2026 virtual Annual Meeting of Stockholders.

I will act as Chairperson of this meeting, and we will begin today with the formal business of the meeting and will follow with a question-and-answer session. Before proceeding further, I'd like to introduce the company's Directors who are present virtually at this meeting. With us today are Melissa Epperly, Zad Nazem, Matt McIlwain, and Matt Posard.

I would also like to welcome the corporate officers who are present virtually at this meeting. Along with me, we have Parag Mallick, Nautilus' Chief Scientist and a member of the Board of Directors of the company; Anna Mowry, Nautilus' Chief Financial Officer; and Matt Murphy, Nautilus' General Counsel.

Finally, I would like to introduce Mr. [Christopher Allody] from our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot